EXPRESSION OF CD200 AND CD148 IN LEUKEMIC B-CELL CHRONIC LYMPHOPROLIFERATIVE DISORDERS

被引：0
|
作者：
Fan, L. [1 ]
Miao, Y. [1 ]
Wang, L. [1 ]
Wu, Y. [1 ]
Xu, W. [1 ]
Li, J. [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P440
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [21] Deciphering leukemic B-cell chronic lymphoproliferative disorders
    Ugo, Valerie
    Leporrier, Nathalie
    Salaun, Veronique
    Letestu, Remi
    Radford-Weiss, Isabelle
    Ramond, Sylvie
    Nataf, Joelle
    Guesnu, Martine
    Picard, Francoise
    Brouzes, Chantal
    Perrot, Jean-Yves
    Valensi, Francoise
    Levy, Vincent
    Ajchenbaum-Cymbalista, Florence
    Troussard, Xavier
    LEUKEMIA & LYMPHOMA, 2006, 47 (10) : 2088 - 2095
  • [22] Characterization of CD200 RNA and Protein Expression in Large B-cell Lymphomas
    McCuiston, Austin M.
    Yang, Wan Rou
    Crane, Genevieve M.
    Gocke, Christopher D.
    Borowitz, Michael J.
    Burns, Kathleen H.
    Duffield, Amy S.
    MODERN PATHOLOGY, 2016, 29 : 361A - 362A
  • [23] Flow Cytometric Assessment of CD200 (OX-2 Membrane Glycoprotein) Expression in B Cell Lymphoproliferative Disorders
    Pillai, V.
    Pozdnyakova, O.
    Charest, K.
    Li, B.
    Dorfman, D. M.
    LABORATORY INVESTIGATION, 2012, 92 : 361A - 362A
  • [24] Flow Cytometric Assessment of CD200 (OX-2 Membrane Glycoprotein) Expression in B Cell Lymphoproliferative Disorders
    Pillai, V.
    Pozdnyakova, O.
    Charest, K.
    Li, B.
    Dorfman, D. M.
    MODERN PATHOLOGY, 2012, 25 : 361A - 362A
  • [25] Characterization of CD200 RNA and Protein Expression in Large B-cell Lymphomas
    McCuiston, Austin M.
    Yang, Wan Rou
    Crane, Genevieve M.
    Gocke, Christopher D.
    Borowitz, Michael J.
    Burns, Kathleen H.
    Duffield, Amy S.
    LABORATORY INVESTIGATION, 2016, 96 : 361A - 362A
  • [26] Utility of CD79b expression in the classification of B-cell chronic lymphoproliferative disorders (BCLPD).
    McCarron, KE
    Hsi, ED
    LABORATORY INVESTIGATION, 1999, 79 (01) : 142A - 142A
  • [27] CD200 expression in hematopoietic neoplasms: Beyond a marker for diagnosis of B-cell neoplasms
    Staub, Renata B.
    Marcondes, Natalia A.
    Rotta, Liane N.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 167
  • [28] Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders
    Poongodi, R.
    Varma, Neelam
    Naseem, Shano
    Parveen, Bose
    Varma, Subhash
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2018, 61 (01) : 50 - 57
  • [29] Utility of CD200 Expression and CD20 Antibody Binding Capacity in Differentiating Chronic Lymphocytic Leukemia from Other Chronic Lymphoproliferative Disorders
    Naseem, Shano
    Poongodi, R.
    Varma, Neelam
    Malhotra, Pankaj
    Varma, Subhash
    BLOOD, 2015, 126 (23)
  • [30] Role of CD200 in differential diagnosis of mature B-cell neoplasm
    Rahman, K.
    Kumar, P.
    Gupta, R.
    Singh, M. K.
    Nityanand, S.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 (04) : 384 - 391
12345